UBS Group’s First Trust Nasdaq Pharmaceuticals ETF FTXH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $137K | Buy |
|
|||||
|
2025
Q2 | $102K | Buy |
|
|||||
|
2025
Q1 | $79.9K | Buy |
|
|||||
|
2024
Q4 | $40.6K | Buy |
|
|||||
|
2024
Q3 | – | Sell |
|
|||||
|
2024
Q2 | $790 | Buy |
|
|||||
|
2024
Q1 | – | Sell |
|
|||||
|
2023
Q4 | $46.4K | Buy |
|
|||||
|
2023
Q3 | – | Sell |
|
|||||
|
2023
Q2 | $112K | Buy |
|
|||||
|
2023
Q1 | $46K | Sell |
|
|||||
|
2022
Q4 | $57K | Buy |
|
|||||
|
2022
Q3 | $10K | Buy |
|
|||||
|
2022
Q2 | – | Sell |
|
|||||
|
2022
Q1 | $22K | Buy |
|
|||||
|
2021
Q4 | $10K | Sell |
|
|||||
|
2021
Q3 | $25K | Buy |
|
|||||
|
2021
Q2 | $23K | Sell |
|
|||||
|
2021
Q1 | $58K | Buy |
|
|||||
|
2020
Q4 | $0 | Buy |
|
|||||
|
2020
Q1 | – | Sell |
|
|||||
|
2019
Q4 | $35K | Sell |
|
|||||
|
2019
Q3 | $38K | Buy |
|
|||||
|
2019
Q2 | $34K | Buy |
|
|||||
|
2019
Q1 | $32K | Buy |
|
|||||
|
2018
Q3 | – | Sell |
|
|||||
|
2018
Q2 | $6K | Buy |
|
|||||
|
2018
Q1 | – | Sell |
|
|||||
|
2017
Q4 | $17K | Buy |
|
|||||
|
2017
Q3 | – | Sell |
|
|||||
|
2017
Q2 | $26K | Sell |
|
|||||
|
2017
Q1 | $26K | Buy |
|